Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 31.97B | 31.95B | 30.95B | 26.17B | 19.18B | 15.82B |
Gross Profit | 22.93B | 22.87B | 22.17B | 18.64B | 13.65B | 11.55B |
EBITDA | 1.46B | 2.41B | 2.71B | 2.63B | 2.05B | 3.98B |
Net Income | 1.72B | 930.00M | 1.05B | 940.53M | 725.81M | 1.69B |
Balance Sheet | ||||||
Total Assets | 22.88B | 22.55B | 23.05B | 21.12B | 16.98B | 14.33B |
Cash, Cash Equivalents and Short-Term Investments | 5.91B | 5.15B | 5.94B | 5.45B | 6.17B | 7.42B |
Total Debt | 8.66B | 9.38B | 10.30B | 10.17B | 7.36B | 6.18B |
Total Liabilities | 13.94B | 14.44B | 15.67B | 14.85B | 11.73B | 9.87B |
Stockholders Equity | 7.09B | 6.43B | 5.53B | 4.70B | 4.17B | 3.60B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.26B | 534.44M | 547.26M | -2.99B | -1.68B |
Operating Cash Flow | 0.00 | 331.05M | 1.79B | 1.68B | 1.34B | -1.39B |
Investing Cash Flow | 0.00 | -241.96M | -1.36B | -1.10B | -4.30B | 6.27B |
Financing Cash Flow | 0.00 | -675.20M | -116.14M | -1.38B | 1.59B | -650.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥16.87B | 23.41 | 0.96% | 3.48% | 2.31% | ||
67 Neutral | ¥20.70B | 29.41 | 0.79% | 5.86% | -23.12% | ||
67 Neutral | ¥20.06B | 146.43 | 0.42% | 1.03% | -84.27% | ||
61 Neutral | ¥19.55B | 18.76 | ― | 6.19% | ― | ||
56 Neutral | HK$24.88B | 3.87 | -2.03% | 6.54% | -0.32% | -67.68% | |
55 Neutral | ¥18.68B | 19.84 | 0.57% | 3.24% | -11.39% | ||
53 Neutral | ¥16.67B | 44.38 | 0.70% | 3.14% | -359.89% |